Lopinavir-Ritonavir

Randomised Evaluation of COVID-19 Therapy

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Trial of Treatments for COVID-19 in Hospitalized Adults

Antiretroviral Regime for Viral Eradication in Newborns

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study

COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women